Inherited Deficiency of the Seventh Component of Complement Associated with Nephritis
Open Access
- 1 June 1978
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 61 (6) , 1602-1610
- https://doi.org/10.1172/jci109080
Abstract
A 46-yr-old female with chronic pyelonephritis was found to lack complement (C) activity by the use of hemolytic screen assays in agarose gels. These assays also revealed a propensity of patient serum to form an activated complex of the fifth and sixth components of C, C5̄6̄. Each of the C component hemolytic activities was present in normal or elevated amounts with the exception of C7, which was undetectable; addition of purified C7 led to the restoration of hemolytic activity. C-dependent phagocytosis, immune adherence, and neutrophil chemotaxis were normal. Family studies demonstrated that the defect was transmitted as an autosomal codominant apparently not linked with alleles at the HLA-A or HLA-B loci. Persisting C5̄6̄ was readily formed in this as compared to normal serum upon incubation with multiple C activators including zymosan, inulin, immune complexes, heat-aggregated human gamma globulin, endotoxin, and agarose. A heat-stable (56°C, 30 min) activity which consumed C7 with time-and temperature-dependent kinetics was detected in plasma and serum, and seemed to be similar to a “C7 inactivator” previously described in another C7-deficient individual. However, this activity was found to have properties identical to those of C5̄6̄ during low ionic strength precipitation and chromatography on Sephadex G-200, to be specifically removed upon passage through an anti-C5 immunoadsorbent column, and to be associated with a small amount of C5̄6̄, suggesting that it represents an expression of small amounts of C5̄6̄ rather than a new C-inhibitory activity. Thus, an individual with chronic nephritis lacking C7 is reported; the utility of a hemolytic screen assay in agarose plates for the detection of such patients is emphasized; persisting C5̄6̄ is shown readily to be formed in this serum; and the presence of C7-consuming activity which is associated with and in all likelihood attributable to C5̄6̄ is shown.This publication has 26 references indexed in Scilit:
- Homozygous C2 deficiency with fulminant lupus erythematosus. severe nephritis via the alternative complement pathwayArthritis & Rheumatism, 1978
- Hereditary C7 deficiency. Diagnosis and HLA studies in a French-Canadian family.Journal of Clinical Investigation, 1977
- C567BAR-INITIATED CYTOLYSIS OF LYMPHOID-CELLS - DESCRIPTION OF PHENOMENON AND STUDIES ON ITS CONTROL BY C567BAR INHIBITORS1977
- 2ND CASE OF HUMAN C3B INHIBITOR (KAF) DEFICIENCY1977
- Binding of the complement intermediate C56 to zymosan in acute phase human sera.1975
- Hereditary deficiency of the sixth component of complement in man. I. Immunochemical, biologic, and family studies.Journal of Clinical Investigation, 1974
- HOMOZYGOUS DEFICIENCY OF C3 IN A PATIENT WITH REPEATED INFECTIONSThe Lancet, 1972
- REACTIVE LYSIS: THE COMPLEMENT-MEDIATED LYSIS OF UNSENSITIZED CELLSThe Journal of Experimental Medicine, 1970
- REACTIVE HAEMOLYSIS - A DISTINCTIVE FORM OF RED CELL LYSIS1968
- Measurements of Complement by Agglutination of Human Erythrocytes Reacting in Immune-AdherenceThe Journal of Immunology, 1963